Delivery Order SPE2DB20D9127-SPE2DB24FPPL3
Award Date
12/20/23
Potential Completion Date
1/12/24
Potential Value
$37K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler. The order, valued at $17,795.10, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The delivery order is under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical items and medical supplies to support military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,123.85 order is for the supply of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Xolair 150 mg/ml syringes. The total potential value of the order is $18,568.80, with a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. to supply a variety of pharmaceutical and medical products, including items such as flumazenil injection, prednisone...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is to provide XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a potential value of $3,094.80 and a completion date of February 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds numerous contracts and indefinite delivery vehicles (IDVs) with DLA to supply a wide range of pharmaceuticals...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is to provide the pharmaceutical product XOLAIR 150 MG/ML SYRINGE with a potential value of $3,094.80 and a completion date of February 9, 2024. This delivery order is issued against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA to provide various pharmaceutical and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 4,564,160,403 units of the pharmaceutical product Xolair 150 mg/mL syringe. This order is part of a larger indefinite delivery contract, SPE2DB24FE6SV, with DMS Pharmaceutical Group valued at up to $4,999,999 through 2025. The contract allows DLA to issue delivery orders for a broad range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The delivery order is for the pharmaceutical product XOLAIR 150 MG/ML SYRINGE and has a firm fixed price of $6,189.60. The period of performance runs through February 13, 2024. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of pharmaceutical items such as the drug XOLAIR 150 MG/ML SYRINGE. The delivery order has a potential value of $6,189.60 and a completion date of February 13, 2024. This appears to be a standalone delivery order and not part of a larger contract vehicle. The contract has no set-aside...
This is a firm fixed-price delivery order award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, valued at $7,737.00. The order is for XOLAIR 150 MG/ML syringes, with an ultimate completion date of March 29, 2024. The award is placed against DMS Pharmaceutical Group's existing indefinite delivery contract #SPE2DB22D9304 with the DLA, which has a ceiling value of up to $4,999,999 through the end of 2025. This contract enables DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE. The single-award, firm fixed-price contract has a ceiling value of $37,137.60 and an ultimate completion date of May 3, 2024. This delivery order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, which has a total potential value of up to $4,999,999 through 2025. The...